{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:28:35Z","timestamp":1789450115238,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jinf.2012.09.008","type":"journal-article","created":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T15:42:36Z","timestamp":1349451756000},"page":"48-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Epidemiology of invasive meningococcal disease in\u00a0Germany, 2002\u20132010, and impact of vaccination with meningococcal C conjugate vaccine"],"prefix":"10.1016","volume":"66","author":[{"given":"Wiebke","family":"Hellenbrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Dehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Frosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2012.09.008_bib1","series-title":"Surveillance of invasive bacterial diseases in Europe 2008\/2009","author":"European Centre for Disease Prevention and Control","year":"2011"},{"issue":"11","key":"10.1016\/j.jinf.2012.09.008_bib2","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/archpedi.162.11.1036","article-title":"Long-term health status in childhood survivors of meningococcal septic shock","volume":"162","author":"Buysse","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jinf.2012.09.008_bib3","first-page":"265","article-title":"Zur Situation bei ausgew\u00e4hlten Infektionkrankheiten in Deutschland: invasive Meningokokken-Erkrankungen im Jahr 2007","volume":"32","author":"Robert","year":"2008","journal-title":"Epidemiol Bull"},{"issue":"357","key":"10.1016\/j.jinf.2012.09.008_bib4","first-page":"360","article-title":"Sachsische Impfkommission beschlie\u00dft Einf\u00fchrung der Varizellen- und Meningokokkenimpfung C als Standardimpfung","volume":"8","author":"S\u00e4chsische","year":"2003","journal-title":"\u00c4rztebl Sachsen"},{"key":"10.1016\/j.jinf.2012.09.008_bib5","first-page":"260","article-title":"Begr\u00fcndung der STIKO-Empfehlungen zur Impfung gegen Pneumokokken und Meningokokken vom Juli 2006","volume":"31","author":"St\u00e4ndige Impfkommission am Robert Koch-Institut","year":"2006","journal-title":"Epidemiol Bull"},{"key":"10.1016\/j.jinf.2012.09.008_bib6","first-page":"235","article-title":"Mitteilung der St\u00e4ndigen Impfkommission am Robert Koch-institut: Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-institut\/stand: Juli 2006","volume":"30","author":"St\u00e4ndige Impfkommission am Robert Koch-Institut","year":"2006","journal-title":"Epidemiol Bull"},{"key":"10.1016\/j.jinf.2012.09.008_bib7","series-title":"Gesetzliche Krankenversicherung Mitglieder, mitversicherte Angeh\u00f6rige und Krankenstand Jahresdurchschnitt 2010","author":"Bundesministerium f\u00fcr Gesundheit","year":"2011"},{"issue":"11","key":"10.1016\/j.jinf.2012.09.008_bib8","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1128\/JCM.00613-06","article-title":"Evidence for indirect nosocomial transmission of Neisseria meningitidis resulting in two cases of invasive meningococcal disease","volume":"44","author":"Elias","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.jinf.2012.09.008_bib9","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.jinf.2012.09.008_bib10","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1128\/jcm.26.11.2465-2466.1988","article-title":"Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity","volume":"26","author":"Hunter","year":"1988","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.jinf.2012.09.008_bib11","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1128\/JCM.39.11.4190-4192.2001","article-title":"Determining confidence intervals when measuring genetic diversity and the discriminatory Abilities of typing methods for microorganisms","volume":"39","author":"Grundmann","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2012.09.008_bib12","first-page":"125","article-title":"Impfquoten bei den Schuleingangsuntersuchungen in Deutschland 2009","volume":"16","author":"Robert","year":"2011","journal-title":"Epid Bull"},{"issue":"4","key":"10.1016\/j.jinf.2012.09.008_bib13","first-page":"1","article-title":"Capture-recapture analysis to estimate the incidence of invasive meningococcal disease in Germany, 2003","volume":"135","author":"Schrauder","year":"2006","journal-title":"Epidemiol Infect"},{"issue":"8","key":"10.1016\/j.jinf.2012.09.008_bib14","first-page":"69","article-title":"Invasive Meningokokken-Erkrankungen: Retrospektive Erhebung von Verdachtsmeldungen nach \u00a7 6 ABs. 1 IfSG Deutschland, 2001\u20132007","author":"Robert","year":"2009","journal-title":"Epid Bull"},{"issue":"1","key":"10.1016\/j.jinf.2012.09.008_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1574-6976.2006.00056.x","article-title":"Multilocus sequence typing for global surveillance of meningococcal disease","volume":"31","author":"Brehony","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"10.1016\/j.jinf.2012.09.008_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1574-6976.2006.00053.x","article-title":"Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines","volume":"31","author":"Trotter","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"10.1016\/j.jinf.2012.09.008_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.inf.0000195594.41449.c6","article-title":"Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands","volume":"25","author":"de Greeff","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.jinf.2012.09.008_bib18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"JID"},{"issue":"12","key":"10.1016\/j.jinf.2012.09.008_bib19","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2012.09.008_bib20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/eri.11.89","article-title":"Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region","volume":"9","author":"Soriano-Gabarr\u00f3","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"5","key":"10.1016\/j.jinf.2012.09.008_bib21","first-page":"840","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of Protection, and modeling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Diagn Lab Immunol"},{"issue":"32","key":"10.1016\/j.jinf.2012.09.008_bib22","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2005.03.045","article-title":"Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain","volume":"23","author":"Larrauri","year":"2005","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.jinf.2012.09.008_bib23","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2143\/TVG.59.20.5001712","article-title":"Vaccinatie tegen meningokokken C in Belgi\u00eb. Kroniek en context van een federaal-regionale campagne","volume":"59","author":"Theeten","year":"2003","journal-title":"Tijdschrift Voor Geneeskunde"},{"key":"10.1016\/j.jinf.2012.09.008_bib24","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1086\/428590","article-title":"Genetic analysis of meningococci carried by children and young adults","volume":"191","author":"Claus","year":"2005","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2012.09.008_bib25","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999\u22122000 and response to a booster: a phase 4 clinical trial","volume":"50","author":"Perrett","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2012.09.008_bib26","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1017\/S0950268805005339","article-title":"The natural history of meningococcal carriage and disease","volume":"134","author":"Trotter","year":"2006","journal-title":"Epidemiol Infect"},{"issue":"23","key":"10.1016\/j.jinf.2012.09.008_bib27","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.23.19885-en","article-title":"Genetic characterisation of the emerging invasive Neisseria meningitidis serogroup Y in Sweden, 2000 to 2010","volume":"16","author":"Thulin-Hedberg","year":"2011","journal-title":"Euro Surveill"},{"issue":"9","key":"10.1016\/j.jinf.2012.09.008_bib28","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1586\/erv.11.103","article-title":"Neisseria meningitidis B vaccines","volume":"10","author":"Panatto","year":"2011","journal-title":"Expert Rev Vaccines"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312002599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312002599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:17:58Z","timestamp":1759007878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445312002599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0163445312002599"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2012.09.008","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of invasive meningococcal disease in\u00a0Germany, 2002\u20132010, and impact of vaccination with meningococcal C conjugate vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2012.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}